{"id":"https://openalex.org/W7204190093","doi":"https://doi.org/10.6084/m9.figshare.33328913","title":"In vitro toxicological evaluation of graphene oxide and its heparin derivatives in African green monkey kidney (Vero) and human keratinocyte (HaCaT) cells","display_name":"In vitro toxicological evaluation of graphene oxide and its heparin derivatives in African green monkey kidney (Vero) and human keratinocyte (HaCaT) cells","publication_year":2026,"publication_date":"2026-08-25","ids":{"openalex":"https://openalex.org/W7204190093","doi":"https://doi.org/10.6084/m9.figshare.33328913"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.33328913","doi":"https://doi.org/10.6084/m9.figshare.33328913","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33328913","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"parent_works":[],"lineage":["https://openalex.org/W7204190093"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.33328913","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148115626","display_name":"Mylane Genro Santos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mylane Genro Santos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114576831","display_name":"Klynsman Gambini Dornelles","orcid":"https://orcid.org/0009-0004-8980-2049","observed_orcids":["https://orcid.org/0009-0004-8980-2049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Klynsman Gambini Dornelles","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114576415","display_name":"Isadora de Souza Liberali Schorn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isadora de Souza Liberali Schorn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114576427","display_name":"ANA CLARA LAVAL ROCKENBACH","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Clara Laval Rockenbach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056169246","display_name":"Rafaeli Albrich Naressi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rafaeli Albrich Naressi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094073173","display_name":"Caroline Arend Birrer","orcid":"https://orcid.org/0009-0009-4339-5595","observed_orcids":["https://orcid.org/0009-0009-4339-5595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Arend Birrer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065958636","display_name":"Daniel Moro Druzian","orcid":"https://orcid.org/0000-0003-1475-5466","observed_orcids":["https://orcid.org/0000-0003-1475-5466"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Moro Druzian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071214220","display_name":"Andr\u00e9 Flores dos Santos","orcid":"https://orcid.org/0000-0002-1348-7036","observed_orcids":["https://orcid.org/0000-0002-1348-7036"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Flores dos Santos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038190351","display_name":"Mirkos Ortiz Martins","orcid":"https://orcid.org/0000-0002-3983-1624","observed_orcids":["https://orcid.org/0000-0002-3983-1624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mirkos Ortiz Martins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108307968","display_name":"CAMILA MEDIANEIRA DA SILVA D\u2019\u00c1VILA","orcid":"https://orcid.org/0009-0004-8136-2413","observed_orcids":["https://orcid.org/0009-0004-8136-2413"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Camila Medianeira da Silva D\u2019\u00c1vilaa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046859160","display_name":"Francine Carla Cadon\u00e1","orcid":"https://orcid.org/0000-0002-6761-9743","observed_orcids":["https://orcid.org/0000-0002-6761-9743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francine Carla Cadon\u00e1","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5011168191","display_name":"Francielle Liz Monteiro","orcid":"https://orcid.org/0000-0002-4698-9657","observed_orcids":["https://orcid.org/0000-0002-4698-9657"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francielle Liz Monteiro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12627","display_name":"Graphene and Nanomaterials Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T12627","display_name":"Graphene and Nanomaterials Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10083","display_name":"Graphene research and applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10079","display_name":"Nanoparticles: synthesis and applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/graphene-oxide","display_name":"graphene oxide","score":1.0},{"id":"https://openalex.org/keywords/nanomaterial-cytotoxicity","display_name":"nanomaterial cytotoxicity","score":0.8809999823570251},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8960000276565552},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.7129999995231628},{"id":"https://openalex.org/keywords/vero-cells","display_name":"Vero cells","score":0.9300000071525574},{"id":"https://openalex.org/keywords/hacat-cells","display_name":"HaCaT keratinocytes","score":0.9599999785423279},{"id":"https://openalex.org/keywords/antiviral-nanomaterials","display_name":"antiviral nanomaterials","score":0.8289999961853027},{"id":"https://openalex.org/keywords/biocompatibility","display_name":"biocompatibility","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C118995209","wikidata":"https://www.wikidata.org/wiki/Q5636366","display_name":"HaCaT","level":3,"score":0.9164999723434448},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.7337999939918518},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.7081999778747559},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6890000104904175},{"id":"https://openalex.org/C89138240","wikidata":"https://www.wikidata.org/wiki/Q3066564","display_name":"Vero cell","level":3,"score":0.5986999869346619},{"id":"https://openalex.org/C2777230088","wikidata":"https://www.wikidata.org/wiki/Q864426","display_name":"Biocompatibility","level":2,"score":0.5595999956130981},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.5529000163078308},{"id":"https://openalex.org/C48349386","wikidata":"https://www.wikidata.org/wiki/Q424361","display_name":"Reactive oxygen species","level":2,"score":0.5041000247001648},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.49300000071525574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47870001196861267},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4781999886035919},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.4700999855995178},{"id":"https://openalex.org/C115537861","wikidata":"https://www.wikidata.org/wiki/Q7645993","display_name":"Surface modification","level":2,"score":0.43970000743865967},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.41190001368522644},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.39890000224113464},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3910999894142151},{"id":"https://openalex.org/C57600042","wikidata":"https://www.wikidata.org/wiki/Q227564","display_name":"Oxidative phosphorylation","level":2,"score":0.39100000262260437},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.3801000118255615},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3522999882698059},{"id":"https://openalex.org/C2777074287","wikidata":"https://www.wikidata.org/wiki/Q1473931","display_name":"Keratinocyte","level":3,"score":0.32499998807907104},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3149999976158142},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.29269999265670776},{"id":"https://openalex.org/C2776649359","wikidata":"https://www.wikidata.org/wiki/Q7798338","display_name":"Thrombogenicity","level":3,"score":0.28690001368522644},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.2799000144004822},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.2556000053882599},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.25099998712539673}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.33328913","doi":"https://doi.org/10.6084/m9.figshare.33328913","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33328913","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.33328913.v1","doi":"https://doi.org/10.6084/m9.figshare.33328913.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33328913.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.33328913","doi":"https://doi.org/10.6084/m9.figshare.33328913","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33328913","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404204475","https://openalex.org/W2057593295","https://openalex.org/W249312728","https://openalex.org/W2948618282","https://openalex.org/W2910949153","https://openalex.org/W3217201930","https://openalex.org/W3206542809","https://openalex.org/W3003605571","https://openalex.org/W2012588499","https://openalex.org/W3014832780"],"abstract_inverted_index":{"Graphene":[0],"oxide":[1,95],"(GO)":[2],"has":[3],"emerged":[4],"as":[5,54,58],"a":[6,59,193],"versatile":[7],"nanomaterial":[8],"(NM)":[9],"for":[10,197],"several":[11],"biomedical":[12,198],"applications":[13],"attributed":[14],"to":[15,26,36,61,70,122,177],"its":[16],"large":[17],"surface":[18],"area,":[19],"abundance":[20],"of":[21,66,74,101,173,186],"oxygenated":[22],"groups,":[23],"and":[24,41,76,87,98,115,137,153,157,170,189,199],"ability":[25],"interface":[27],"with":[28,50,78,166],"biomolecules.":[29],"However,":[30],"concerns":[31],"regarding":[32],"cytotoxicity,":[33],"often":[34],"linked":[35],"oxidative":[37,139],"stress,":[38,140],"membrane":[39],"disruption,":[40],"excessive":[42],"cellular":[43],"uptake,":[44],"limit":[45],"therapeutic":[46],"potential.":[47],"Surface":[48],"functionalization":[49,163],"biocompatible":[51],"polymers,":[52],"such":[53],"heparin,":[55,190],"was":[56,69,164],"explored":[57],"strategy":[60],"improve":[62],"performance.":[63],"The":[64],"aim":[65],"this":[67],"study":[68],"examine":[71],"the":[72,181],"biocompatibility":[73],"GO":[75,79,152,188],"heparin":[77,162],"(GO@Heparin":[80],"2.5":[81],"or":[82,111],"5%)":[83],"utilizing":[84],"Vero":[85,107],"(epithelial)":[86],"HaCaT":[88,126],"(keratinocyte)":[89],"cells":[90,127],"by":[91],"MTT":[92],"assay,":[93],"nitric":[94],"(NO)":[96],"quantification,":[97],"DCFH-DA":[99],"measurements":[100],"reactive":[102],"oxygen":[103],"species":[104],"(ROS).":[105],"In":[106],"cells,":[108],"GO@Heparin":[109,154,191],"maintained":[110],"increased":[112,134],"metabolic":[113],"activity":[114,185],"markedly":[116],"reduced":[117],"ROS":[118,174],"production":[119],"at":[120],"low":[121],"intermediate":[123],"concentrations,":[124],"whereas":[125],"exhibited":[128],"more":[129],"limited":[130],"response.":[131],"Heparin":[132],"alone":[133],"cell":[135,168],"viability":[136,169],"decreased":[138],"supporting":[141],"intrinsic":[142],"cytoprotective":[143],"activity.":[144],"At":[145],"higher":[146],"nominal":[147],"concentrations":[148],"(\u2265125":[149],"\u00b5g/ml),":[150],"both":[151,187],"induced":[155],"concentration\u2011":[156],"time\u2011dependent":[158],"cytotoxic":[159],"effects.":[160],"Overall,":[161],"associated":[165],"improved":[167],"favorable":[171],"modulation":[172],"generation":[175],"compared":[176],"pristine":[178],"GO.":[179],"Considering":[180],"previously":[182],"reported":[183],"antiviral":[184,200],"represents":[192],"promising":[194],"hybrid":[195],"NM":[196],"applications.":[201]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-08-26T00:00:00"}